Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Assets Average (2018 - 2026)

Kamada's (KMDA) quarterly Assets Average came in at $383.1 million in Q2 2026, up 3.08% on a YoY basis from $371.6 million in Q2 2025, and up 0.58% quarter-over-quarter from $380.9 million in Q1 2026.

Analysis

Kamada (KMDA) Assets Average (2018 - 2026) Analysis & Trends

Kamada (KMDA) has reported Assets Average for 9 consecutive years, with $383.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets Average rose 3.08% year-over-year to $383.1 million; the trailing twelve-month figure through Jun 2026 stood at $383.1 million (up 3.08% YoY), and the FY2025 full-year result was $375.5 million, up 3.27% from the prior year.
  • Assets Average rose to $383.1 million in Q2 2026 per KMDA's latest filing, from $380.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $383.1 million in Q2 2026 and bottomed at $303.6 million in Q2 2022.
  • Historically, Assets Average has averaged $345.7 million across 5 years, with a median of $348.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Assets Average jumped 47.62% in 2022, then climbed 1.92% in 2026.
  • Over 5 years, Assets Average stood at $321.0 million in 2022, then gained by 7.78% to $346.0 million in 2023, then rose by 4.55% to $361.7 million in 2024, then rose by 4.49% to $378.0 million in 2025, then gained by 1.36% to $383.1 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $383.1 million, $380.9 million, and $378.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 5.34 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 5.51 Bn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn 383.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 383.09 Mn
Mar 31, 2026 380.87 Mn
Dec 31, 2025 377.96 Mn
Sep 30, 2025 372.69 Mn
Jun 30, 2025 371.64 Mn
Mar 31, 2025 373.68 Mn
Dec 31, 2024 361.73 Mn
Sep 30, 2024 351.12 Mn
Jun 30, 2024 347.11 Mn
Mar 31, 2024 349.04 Mn
Dec 31, 2023 345.98 Mn
Sep 30, 2023 325.72 Mn
Jun 30, 2023 315.59 Mn
Mar 31, 2023 319.59 Mn
Dec 31, 2022 321.01 Mn
Sep 30, 2022 311.89 Mn
Jun 30, 2022 303.62 Mn
Mar 31, 2022 310.88 Mn
Dec 31, 2021 267.60 Mn
Sep 30, 2021 216.44 Mn